-
EP4547250
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP Citations: EP4547250
| Cited in | Search | Type: | Patent literature | Publication No.: | US2022096504
[X] (BLUMSTOCK JUDITH et al.) [X] 1-15 * paragraphs [0007]-[0010], [0059]-[0072], [0092], [0226]-[0227]; claims 1, 13, 18, 23, 24 * | Type: | Non-patent literature | Publication information: | [Y] JASTER ALAINA M ET AL: "Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents", PSYCHOPHARMACOLOGY, SPRINGER VERLAG, BERLIN, DE, vol. 239, no. 6, 2 March 2022 (2022-03-02), pages 1665 - 1677, XP037860911, ISSN: 0033-3158, [retrieved on 20220302], DOI: 10.1007/S00213-022-06092-X [Y] 1-15 * Abstract, Pg 1672 * | DOI: | http://dx.doi.org/10.1007/s00213-022-06092-x | Type: | Non-patent literature | Publication information: | [Y] WINTER ET AL: "Psilocybin-induced stimulus control in the rat", PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, ELSEVIER, US, vol. 87, no. 4, 13 August 2007 (2007-08-13), pages 472 - 480, XP022197313, ISSN: 0091-3057, DOI: 10.1016/J.PBB.2007.06.003 [Y] 1-15 * Abstract, section 3. Results 3.1. Tests of antagonism, pg 477 section discussion * | DOI: | http://dx.doi.org/10.1016/j.pbb.2007.06.003 | Cited in | International search | Type: | Patent literature | Publication No.: | WO2019081764
[X] (CONSEJO SUPERIOR INVESTIGACION et al.) [X] 1-69 * See: Abstract; page 12, lines 27-28; page 28, paragraph 2; page 30, lines 10-21; examples. * | Type: | Patent literature | Publication No.: | WO2020212952
[X] (COMPASS PATHFINDER LTD et al.) [X] 1-69 * See: Abstract; paragraph bridging pages 69 and 70; page 109, point 7; examples 11-13. * | Type: | Patent literature | Publication No.: | US2021267977
[X] (LIECHTI MATTHIAS EMANUEL et al.) [X] 1-69 * See: Abstract; [0007]; [0031]-[0032]; [0040]; [0044]; examples 1 and 3. * | Type: | Patent literature | Publication No.: | US2022395499
[P,X] (KARLIN DANIEL R et al.) [P,X] 1-69 * See: Abstract; [0002]; [0019]. * | Type: | Patent literature | Publication No.: | WO2022195489
[P,X] (TRYP THERAPEUTICS INC et al.) [P,X] 1-69 * See: [0072]; [0154]. * | Type: | Patent literature | Publication No.: | WO2023107966
[P,X] (TERRAN BIOSCIENCES INC et al.) [P,X] 1-69 * See: examples 19a-191; Table 162. * | Type: | Patent literature | Publication No.: | WO2023086962
[P,X] (TERRAN BIOSCIENCES INC et al.) [P,X] 1-69 * See: [00222]; [00376]-[00390]; [00399]-[00411]; [00421]-[00434]; [00512]-[00527]; [00536]-[00549]; [00656]-[00670]; [00679]-[00692]; [00761]-[00776]; examples 13-21. * | Type: | Non-patent literature | Publication information: | [X] CANAL CLINTON E., BOOTH RAYMOND G., MORGAN DRAKE: "Support for 5-HT2C receptor functional selectivity invivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model", NEUROPHARMACOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 70, 1 July 2013 (2013-07-01), AMSTERDAM, NL, pages 112 - 121, XP093126860, ISSN: 0028-3908, DOI: 10.1016/j.neuropharm.2013.01.007 [X] 1-69 * See: Introduction; experiments 2 and 4. * | DOI: | http://dx.doi.org/10.1016/j.neuropharm.2013.01.007 | Type: | Non-patent literature | Publication information: | [X] VALERIANI, G. ET AL.: "Olanzapine as the ideal ''trip terminator''? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms", HUM. PSYCHOPHARMACOL CLIN EXP, vol. 30, 2015, pages 249 - 254, XP071720869, DOI: 10.1002/hup.2431 [X] 1-69 * See: page 250, col. 2; page 251, col. 2 - page 252, col. 1. * | DOI: | http://dx.doi.org/10.1002/hup.2431 | Type: | Non-patent literature | Publication information: | [XA] TAKAGI HIROSHI, SHIGERU YAMAMOTO; SHUJI TAKAORI; KIKUO OGIU: "THE EFFECT OF LSD AND RESERPINE ON THE CENTRAL NERVOUS SYSTEM OF THE CAT", THE JAPANESE JOURNAL OF PHARMACOLOGY, THE JAPANESE PHARMACOLOGICAL SOCIETY, KYOTO JP, vol. 7, no. 2, 1 January 1958 (1958-01-01), Kyoto JP , pages 119 - 134, XP093126868, ISSN: 0021-5198, DOI: 10.1254/jjp.7.119 [X] 1-69 * . See: Table 1; Figures 1 & 6; first and last paragraph of Discussion. See: Table 1; Figures 1 & 6; first and last paragraph of Discussion. * [A] 1-69 | DOI: | http://dx.doi.org/10.1254/jjp.7.119 |